Ledger.Open graph →
SEC Form D · filed February 6, 2014

Clarus Lifesciences III, L.P

Offering
$375.0M
Sold
—
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
CAMBRIDGE, MA
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Nicholas J. Simon · Cambridge, MAExecNicholas Galakatos · Cambridge, MAExecKurt C. Wheeler · Cambridge, MAExecRobert W. Liptak · Cambridge, MAExecClarus Ventures Iii Gp, L.P · Cambridge, MADirectorDennis Henner · Cambridge, MAExecClarus Ventures Iii, Llc · Cambridge, MADirectorClarus Ventures Iii Gp, L.P · Cambridge, MADirectorClarus Ventures Iii, Llc · Cambridge, MADirectorMichael J. Cowan · London, United KingdomExecTimothy J. Linehan · London, United KingdomExecStephen C. Butt · London, United KingdomExecChris B. Cowie · New York, NYExecSonia E. Gardner · NEW YORK, NYExecClarus Ventures Iii Gp, L.P · Cambridge, MADirectorClarus Ventures Iii, Llc · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗